Literature DB >> 17030789

Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses.

Alexander A Navarini1, Mike Recher, Karl S Lang, Panco Georgiev, Susanne Meury, Andreas Bergthaler, Lukas Flatz, Jacques Bille, Regine Landmann, Bernhard Odermatt, Hans Hengartner, Rolf M Zinkernagel.   

Abstract

The reason why severe localized or systemic virus infections enhance and aggravate bacterial superinfection is poorly understood. Here we show that virus-induced IFN type I caused apoptosis in bone marrow granulocytes, drastically reduced granulocyte infiltrates at the site of bacterial superinfection, caused up to 1,000-fold higher bacterial titers in solid organs, and increased disease susceptibility. The finding that the innate antiviral immune response reduces the antibacterial granulocyte defense offers an explanation for enhanced susceptibility to bacterial superinfection during viral disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17030789      PMCID: PMC1622858          DOI: 10.1073/pnas.0607325103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Immune evasion by staphylococci.

Authors:  Timothy J Foster
Journal:  Nat Rev Microbiol       Date:  2005-12       Impact factor: 60.633

2.  Suppression of virus-specific antibody production by CD8+ class I-restricted antiviral cytotoxic T cells in vivo.

Authors:  D Moskophidis; H Pircher; I Ciernik; B Odermatt; H Hengartner; R M Zinkernagel
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

3.  Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice.

Authors:  H W Rogers; E R Unanue
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

4.  Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae.

Authors:  Jonathan A McCullers; Kimberly C Bartmess
Journal:  J Infect Dis       Date:  2003-03-06       Impact factor: 5.226

5.  The role of Kupffer cells and regulation of neutrophil migration into the liver by macrophage inflammatory protein-2 in primary listeriosis in mice.

Authors:  Y Ebe; G Hasegawa; H Takatsuka; H Umezu; M Mitsuyama; M Arakawa; N Mukaida; M Naito
Journal:  Pathol Int       Date:  1999-06       Impact factor: 2.534

Review 6.  Prevention of lymphocyte apoptosis--a potential treatment of sepsis?

Authors:  Richard S Hotchkiss; Craig M Coopersmith; Irene E Karl
Journal:  Clin Infect Dis       Date:  2005-11-15       Impact factor: 9.079

7.  Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus.

Authors:  D Binder; J Fehr; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

8.  Reaction of squirrel monkeys to intratracheal inoculation with influenza/A/New Jersey/76 (swine) virus.

Authors:  R F Berendt; W C Hall
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

9.  Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients.

Authors:  J U Gutterman; S Fine; J Quesada; S J Horning; J F Levine; R Alexanian; L Bernhardt; M Kramer; H Spiegel; W Colburn; P Trown; T Merigan; Z Dziewanowski
Journal:  Ann Intern Med       Date:  1982-05       Impact factor: 25.391

10.  Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes.

Authors:  Victoria Auerbuch; Dirk G Brockstedt; Nicole Meyer-Morse; Mary O'Riordan; Daniel A Portnoy
Journal:  J Exp Med       Date:  2004-08-09       Impact factor: 14.307

View more
  75 in total

1.  cPLA2 regulates the expression of type I interferons and intracellular immunity to Chlamydia trachomatis.

Authors:  Mark J Vignola; David F Kashatus; Gregory A Taylor; Christopher M Counter; Raphael H Valdivia
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

2.  Influenza virus primes mice for pneumonia from Staphylococcus aureus.

Authors:  Amy R Iverson; Kelli L Boyd; Julie L McAuley; Lisa R Plano; Mark E Hart; Jonathan A McCullers
Journal:  J Infect Dis       Date:  2011-01-28       Impact factor: 5.226

Review 3.  Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease.

Authors:  Xuetao Cao
Journal:  Nat Rev Immunol       Date:  2016-01       Impact factor: 53.106

Review 4.  Systemic responses during local viral infections: type I IFNs sound the alarm.

Authors:  Carolina B López; Tamar Hermesh
Journal:  Curr Opin Immunol       Date:  2011-07-13       Impact factor: 7.486

Review 5.  The impact of successive infections on the lung microenvironment.

Authors:  Arnaud Didierlaurent; John Goulding; Tracy Hussell
Journal:  Immunology       Date:  2007-12       Impact factor: 7.397

6.  Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness.

Authors:  David M Morens; Jeffery K Taubenberger; Anthony S Fauci
Journal:  J Infect Dis       Date:  2008-10-01       Impact factor: 5.226

Review 7.  Crosstalk between type I and II interferons in regulation of myeloid cell responses during bacterial infection.

Authors:  William J Crisler; Laurel L Lenz
Journal:  Curr Opin Immunol       Date:  2018-06-07       Impact factor: 7.486

8.  New look at an old problem: bacterial superinfection after influenza.

Authors:  Kevan L Hartshorn
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

9.  Type I interferon signaling exacerbates Chlamydia muridarum genital infection in a murine model.

Authors:  Uma M Nagarajan; Daniel Prantner; James D Sikes; Charles W Andrews; Anna M Goodwin; Shanmugam Nagarajan; Toni Darville
Journal:  Infect Immun       Date:  2008-07-28       Impact factor: 3.441

Review 10.  A recent perspective on alcohol, immunity, and host defense.

Authors:  Gyongyi Szabo; Pranoti Mandrekar
Journal:  Alcohol Clin Exp Res       Date:  2008-12-02       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.